IQM Quantum Computers Oyj

The clear European superconducting-QC leader with the deepest on-prem install base in the industry, a sovereign-funded demand base, and a fully-funded balance sheet to reach error-corrected machines — a scarce non-US way to own the quantum buildout.

• Install-base leadership: 23 systems sold / 18 delivered on-prem — the largest publicly disclosed delivery count among quantum peers — at 4 of the world's top-10 supercomputing centers, a defensible reference base.
• Sovereign/strategic demand: EU 'quantum sovereignty' funding (EuroHPC Euro-Q-Exa, LRZ, CSC/VTT, Czech national center) gives a customer base that buys for strategic, not purely ROI, reasons and is harder for US vendors to displace in Europe.
• Fully funded to the next milestone: ~$465M expected post-merger cash plus blue-chip backers (BlackRock, Tesi, Ten Eleven, Ilmarinen, Vanguard board seat) — runway through the Halocene/error-correction phase without near-term dilution panic.
• Real technical progress: 99.9% two-qubit gate fidelity (test systems), and June-2026 directional tile codes claiming up to ~1000x lower logical error rate at ~30 physical qubits/logical — credible steps toward near-term fault tolerance.
• Scarcity / first-mover listing: first listed European quantum pure-play; ~$36M FY25 revenue and >$100M bookings give it more commercial traction than several US-listed quantum names trading at multi-billion caps.
• Full-stack + on-prem differentiation: open-architecture, owned-hardware deployment tightly integrated with HPC suits security-sensitive government and enterprise buyers who won't run on shared cloud QPUs.

A pre-profit, cash-burning hardware company (€54M loss on €31M revenue) entering public markets via SPAC at a ~$1.8B valuation, into a brutally competitive, possibly hype-inflated quantum sector where well-capitalized US/Chinese giants and several qubit modalities could leave superconducting—or IQM specifically—behind.

• Money-losing and sub-scale: ~€31M revenue vs. €54.4M net loss — burn exceeds revenue, and the path to profitability depends on fault tolerance that the whole industry is years from, with no disclosed margins or unit economics.
• SPAC-listing red flags: de-SPAC valuations have a poor track record; ~$1.8B on ~$36M revenue is ~50x sales, and lumpy capital-equipment bookings can mask demand volatility once sovereign grant cycles turn.
• Modality risk: superconducting is one of several competing approaches — neutral-atom (Pasqal, QuEra), trapped-ion (IonQ, Quantinuum), cat-qubit (Alice & Bob), photonic (PsiQuantum, Xanadu); IQM's bet could be the wrong architecture for scalable fault tolerance.
• Deep-pocketed competition: IBM, Google (acquired Atlantic Quantum), Microsoft, AWS, NVIDIA and US-listed IonQ/Rigetti/D-Wave have larger engineering teams and capital; IQM's ~$465M is small versus their multi-billion programs.
• Customer concentration & grant dependence: revenue leans on a handful of HPC centers and EU programs; a budget cut, a single delivery slip, or a competing national champion could swing results materially.
• Quantum-hype cycle risk: the sector trades on narrative; a broad de-rating (or a 'quantum winter' if fault tolerance disappoints) would hit a freshly-listed, loss-making name hardest. Non-US ADS — analysis-only, not a buy recommendation.